Cannabis and psychosis: minimising harm while maximising therapeutic potential.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 40931726.
- Also identified by DOI 10.1192/bjp.2025.10389 and PMC identifier 7618226.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cannabis use increases the risk of psychosis, but cannabis-based medicinal products may provide additional therapeutic opportunities. Decriminalisation of cannabis has led to wider availability in certain jurisdictions, while in the UK regulated medicinal preparations are not readily accessible. A more balanced approach could reduce harms while maximising potential therapeutic benefits.
Medical subject headings
- Psychotic Disorders
- Cannabis
- Medical Marijuana